Skip to content

Text · Comparison of two versions

Changes from report parliamentary committee draft to plenary report

FEMM-PR-782188 → A-10-2026-0200

From
FEMM-PR-782188 report parliamentary committee draft of 7 Jan 2026
To
A-10-2026-0200 Plenary report of 26 Aug 2026
Changes
11 changes to the text
Paragraphs
+126 added · −33 removed · 10 changed
More facts (3)
Title (from)
on gender inequalities in health, specifically as regards gender-specific conditions
Title (to)
on gender inequalities in health, specifically as regards gender-specific conditions
AI: What changed, in short Written by AI from the official text — check the source · deepseek-flash · 16 Sept 2026

The new version replaces the recitals and most operative paragraphs with a broader set of commitments on women's health, covering access barriers, underfunded conditions, mental health, digital health and global health.123 It adds measures on clinical trials, data collection, training for health professionals, a European Reference Network on women's health and responses to gender-based violence and harmful practices.456 It adds paragraphs on cardiovascular disease, cancer, sexual and reproductive health and rights, abortion, contraception, maternity care, fertility, menopause, endometriosis, diabetes and other conditions.7 It adds funding commitments for research and prevention, an expert group, a women's health strategy with indicators, and support for civil society organisations.891011

The notes class 11 changes as substance, 0 as formal, 0 as wording only.

Read the changes · Report a problem

Every difference

The full paragraph comparison, packaging included; long runs of unchanged paragraphs are folded. One part of the text per page.

Part 4 of 5: Paragraphs 181–186

Change 11

Added62. Calls for the Commission to develop and implement a specific women’s health strategy, embedded in the European Pillar of Social Rights at EU level, to be implemented across the Member States, with the aim of reducing gender health gaps, boosting public research into gender-specific conditions and guaranteeing equal access to healthcare across the EU; stresses that the strategy should include specific indicators and reporting requirements regarding progress; calls on the Commission to prioritise earmarked funding under the new European Competitiveness Fund and Horizon Europe 2028-2034 (FP10) for research into women’s health; calls for dedicated, ring-fenced and traceable EU funding for women’s health, gender-specific conditions and sexual and reproductive healthcare, as well as for projects aiming to close sex- and gender-based data gaps; underscores the need for adequate funding because, on average, women face greater socio-economic constraints and are therefore more dependent on public healthcare and social services; highlights that the underfunding of care for gender-specific conditions can have negative impacts on Member States’ economies and workforce;

Added63. Emphasises the critical role of civil society organisations in providing needs-based, community-level and peer-to-peer healthcare services, particularly for women facing poverty, discrimination or social exclusion; stresses that these organisations act as a bridge between patients and public institutions, and also work to advance gender equality and SRHR, collect data on women’s health experiences and needs, prevent online health scams, and contribute to ensuring more gender-inclusive laws and policies in the field of healthcare; calls for their role to be explicitly acknowledged, in the upcoming European Competitiveness Fund and AgoraEU programme, through the earmarking of sufficient levels of funding for civil society organisations working on gender equality and SRHR in both programmes; expresses concern about the shrinking civic space and the decrease in funding available for civil society organisations working on women’s health and rights across the EU; strongly condemns the Commission’s decision to unexpectedly cut funding, including operating grants for health civil society organisations, in the EU4Health programme, and urges the Commission to immediately reinstate adequate funding for these health non-governmental organisations;

Added64. Calls on the Commission and the Member States to promote greater participation of women in all aspects of scientific research, both as researchers and as participants in research; recommends that measures be adopted to remove barriers to women’s career progression in science and to ensure equal opportunities in access to research funding and management positions; stresses that a more gender-balanced composition of research teams and greater participation of women in clinical trials will contribute to improving the quality and reliability of health outcomes;

°

° °

65. Instructs its President to forward this resolution to the Council and the Commission.

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Retrieved
26 September 2026

Cite as

European Parliament (2026). “Changes between FEMM-PR-782188 and A-10-2026-0200”. Text, 26 August 2026. from FEMM-PR-782188, to A-10-2026-0200, reference 2025/2074(INI). EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/FEMM-PR-782188/compare/A-10-2026-0200?all=1&part=4 (retrieved 26 September 2026). Data: European Parliament Open Data, https://data.europarl.europa.eu/ (CC BY 4.0).
BibTeX
@misc{epw-text-2026-08-26,
  author = {{European Parliament}},
  title = {{Changes between FEMM-PR-782188 and A-10-2026-0200}},
  year = {2026},
  date = {2026-08-26},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/FEMM-PR-782188/compare/A-10-2026-0200?all=1&part=4}},
  url = {https://news.eu-parl.st-solutions.dev/texts/FEMM-PR-782188/compare/A-10-2026-0200?all=1&part=4},
  urldate = {2026-09-26},
  publisher = {EU Parl Watch Research},
  note = {Text. from FEMM-PR-782188, to A-10-2026-0200, reference 2025/2074(INI). Data: European Parliament Open Data (CC BY 4.0)}
}